McKesson Corporation
MCK | NYSE
$1,000.03
+$5.45 (+0.55%)
Nov 2, 2026, 9:31 AM ET · Market open
Company Profile
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Key Executives
| Name | Position |
|---|---|
| Brian S. Tyler | CEO & Chairman |
| Francisco Fraga | Executive Vice President, Chief Information Officer & Chief Technology Officer |
| Kenny K. Cheung | Executive Vice President & Chief Financial Officer |
| Michele Lau | Executive Vice President & Chief Legal Officer |
| Jeni Dominguez | Head of Investor Relations |
| Kirk Kaminsky | Executive Vice President & Group President of North American Pharmaceutical Services |
| LeAnn Smith | Executive Vice President & Chief Human Resources Officer |
| Martin Koffel | Executive Officer |
| Napoleon Rutledge Jr. | Senior Vice President, Controller & Chief Accounting Officer |
| Paula Adkison | Senior Vice President of Corporate Finance, Investor Relations & Strategic Finance |
| Saralisa C. Brau | Corporate Secretary |
| Stanton McComb | President of Medical-Surgical |
| Todd Kleinow | VP of Strategic Distribution & Operations |
| Yiyi Frechette | Director of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 10, 2026 | 4 | Filing |
| Aug 28, 2026 | 8-K | Current Report |
| Aug 11, 2026 | 4 | Filing |
| Aug 11, 2026 | 4 | Filing |
| Aug 10, 2026 | 3 | Filing |
| Aug 05, 2026 | 10-Q | Quarterly Report |
| Aug 05, 2026 | 8-K | Current Report |
| Jul 24, 2026 | 8-K | Current Report |
| Jul 23, 2026 | 4 | Filing |
| Jul 23, 2026 | 4 | Filing |
McKesson Corporation
| Country | United States |
| IPO Date | Nov 10, 1994 |
| Industry | Medical - Distribution |
| Sector | Healthcare |
| Employees | 42,300 |
| CEO | Brian S. Tyler |
Contact Details
6555 State Highway 161 Irving,
Texas 75039 United States
Stock Details
| Ticker Symbol | MCK |
| Exchange | NYSE |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0000927653 |
| CUSIP Number | 58155Q103 |
| ISIN Number | US58155Q1031 |
| SIC Code | 5122 |
Recent News
- 3 days ago / zacks.comStay Ahead of the Game With McKesson (MCK) Q2 Earnings: Wall Street's Insights on Key Metrics
- 5 days ago / zacks.comMcKesson (MCK) Earnings Expected to Grow: Should You Buy?
- 5 days ago / zacks.comMcKesson (MCK) Stock Dips While Market Gains: Key Facts
- 6 days ago / zacks.comHere's Why McKesson (MCK) is a Strong Momentum Stock
- 11 days ago / seekingalpha.comMcKesson: AI And FDA Overhaul Likely To Overtake Regulatory Drag In 2027
- 12 days ago / zacks.comIs Trending Stock McKesson Corporation (MCK) a Buy Now?
- 13 days ago / zacks.comMcKesson (MCK) Outperforms Broader Market: What You Need to Know
- 18 days ago / benzinga.comJim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'
- 19 days ago / zacks.comMcKesson (MCK) Ascends While Market Falls: Some Facts to Note
- 20 days ago / zacks.comMcKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?
Add to Watchlist
Select watchlists to add or remove MCK